BRAIN Biotech AG Capital Reinvestment Ratio

Latest as of June 2024: 1.40x

BRAIN Biotech AG capital reinvestment ratio. BRAIN Biotech AG (BNN) has a Capital Reinvestment Ratio of 1.40x as of June 2024, meaning it reinvests 1% of its operating cash flow (€516.00K) in capital expenditures (€720.00K). Check how aggressively does BRAIN Biotech AG reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

1.40x

Capex / Operating Cash Flow

Operating Cash Flow

€516.00K

EUR

Capital Expenditures

€720.00K

EUR

Data as of

Jun 2024

Most recent filing

BRAIN Biotech AG Capital Reinvestment Ratio by Year (None–None)

BRAIN Biotech AG capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see BRAIN Biotech AG (BNN) cash conversion ratio.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow